期刊文献+

白细胞介素18在结肠腺癌及腺瘤中的作用探讨 被引量:3

Interleukin 18 Expression in Colon Cancer and Adenoma
下载PDF
导出
摘要 目的 了解白细胞介素 18(IL - 18)在结肠腺癌及腺瘤中的表达及其作用。方法 采用免疫组化方法检测 IL - 18在 2 1例结肠腺瘤及 33例结肠癌中的表达。结果 结肠腺癌、腺瘤及非癌非瘤粘膜上皮 IL - 18表达的阳性率分别为 78.8% ,10 0 % ,10 0 % ,无显著性差异 (P>0 .0 5 )。无表达主要集中在中、低分化腺癌 ,腺癌分化程度越高 ,IL - 18表达越强 (P<0 .0 5 )。结肠腺瘤阳性率与伴随的不典型增生程度无明显相关 (P>0 .0 5 )。结论  IL - 18在结肠腺瘤中表达仍较丰富 ,但结肠癌中表达减少或不表达 ,分化越低 。 Objective To investigate the expression of interleukin 18 in mucosa of colon cancer and adenoma. Methods Expression of interleukin 18 was measured with immunohistochemical staining. Results The expression rates of IL 18 in colon cancer, adenoma and relative normal mucosa were 78.8%,100% and 100%, respectively ( P >0.05). In the case of colon cancer, the higher the cancer was differentiated, the higher the IL 18 expression level was observed ( P <0.05). In the case of colon adenoma, no significant relation was noted between the grade of dysplasia and the expression of IL 18 ( P >0.05). Conclusion In colon adenoma, all mucosae express IL 18. But in colon cancer, IL 18 expression is decreased or absent, and the lower the cancer is differentiated, the lower will be the level of IL 18 expression in epithelium.
出处 《四川大学学报(医学版)》 CAS CSCD 北大核心 2003年第2期262-264,共3页 Journal of Sichuan University(Medical Sciences)
关键词 白细胞介素18 结肠腺瘤 结肠癌 Interleukin 18 Adenomatous polyps Colonic neoplasms
  • 相关文献

参考文献7

  • 1[1]Takeuchi M, Nishizaki Y, Sano O, et al. Immunohistochemical and immune-electron-microscopic detection of interferon-γ-inducing factor("interleukin 18") in mouse intestinal epithelial cells. Cell Tissue Res, 1997; 289(3):499
  • 2[2]Carson WE, Dierksheide JE, Jabbour S, et al. Coadministration of IL-18 and IL-12 induces a fatal inflammatory response in mice: critical role of natural killer cell IFN-γ production and STAT-mediated signal transduction. Blood, 2000; 96(4):1465
  • 3[3]Ohtsuki T, Micallef MJ, Kohno K, et al. Interleukin-18 enhances Fas ligand expression and induces apoptosis in Fas-expressing human myelomonocytic KG-1 cells. Anticancer Res, 1997; 17:3253
  • 4[4]Tanaka F, Hashimoto W, Okamura H, et al. Rapid generation of potent and tumor-specific cytotoxic T lymphocytes by interleukin 18 using dendritic cells and natural killer cells. Cancer Res, 2000; 60(17):4838
  • 5[5]Pages F, Berger A, Henglein B, et al. Modulation of interleukin-18 expression in human colon carcinoma: consequences for tumor immune surveillance. Int J Cancer, 1999; 84(3):326
  • 6[6]Tasaki K, Yoshida Y, Maeda T, et al. Protective immunity is induced in murine colon carcinoma cells by the expression of interleukin-12 or interleukin-18, which activate type 1 helper T cells. Cancer Gene Ther, 2000; 7(2);247
  • 7[7]Yoshimura K, Hazama S, Iizuka N, et al. Successful immunogene therapy using colon cancer cells (colon 26) transfected with plasmid vector containing mature interleukin-18 cDNA and the Igkappa leader sequence. Cancer Gene Ther, 2001; 8(1):9

同被引文献7

引证文献3

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部